Key facts
- BlackRock, Inc. filed SCHEDULE 13G/A for UTAH MEDICAL PRODUCTS INC Common Stock (UTMD).
- Disclosed ownership: 5%.
- Date of event: 31 Dec 2024.
BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for UTAH MEDICAL PRODUCTS INC Common Stock (UTMD)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- UTMD
- Shares outstanding
- 3,392,636 shares
- Disclosed Ownership
- 168,614 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Feb 2025, 13:23:43 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 17 Jul 2025
- SEC
- View on sec.gov
Key filing fact
BlackRock, Inc. disclosed 5% ownership in UTAH MEDICAL PRODUCTS INC Common Stock (UTMD) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 13:23.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5% | 168,614 | 165,393 | 0 | Spencer Fleming | Managing Director |
CIK / CUSIP context first